Helper strategy in tumor immunology: Expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

Author:

Forni Guido,Fujiwara Hiromi,Martino Frank,Hamaoka Toshiyuki,Jemma Cristina,Caretto Patrizia,Giovarelli Mirella

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference104 articles.

1. Foley FJ: Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 13: 835?837, 1953

2. Prehn RT, Main JM: Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769?778, 1957

3. Klein G, Sjogren HD, Klein E, Hellstrom KE: Demonstration of host resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20: 1561?1572, 1960

4. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JJT, Seipp CA, Simpson CG, White DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. New Eng J Med 316: 889?883, 1987

5. Cerottini JC, Brunner KT: Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 18: 67?79, 1984

Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3